GOLDENWELL BIOTECH (GWLL) Stock Overview

Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. It is developing five products, including JI MAI—bovine cardiac vascular active peptide; cartilage peptide, a type II collagen peptide; and Double Proline AG – 3D active collagen peptide, as well as Se Plus tablets and sugar master tablets. The company was incorporated in 2019 and is based in Twinsburg, Ohio.